Autonomix medical, inc. demonstrates sustained pain reduction, quality of life gains and 100% zero opioid use in longer-term post hoc analysis from poc 1 study

New longer-term post hoc analysis results of responders (n=6) 1 showed long-lasting, durable pain reduction of nearly 66%, or a mean 5.08 reduction on the vas pain scale, in patients with severe pancreatic cancer pain

AMIX Ratings Summary

AMIX Quant Ranking